Sign in
4

Changes in Ownership

Prelude Therapeutics Inc Filed Acc 0000947871-21-000053

Options or other derivatives

  • Director bought 41,700 shares at $60.00 ($2,502,000)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bonita David P Director 2021-01-11 Purchase · Non-Voting Common Stock +41,700 $60.00 $2,502,000 5,596,886 I: show line 1 in the form
Loading xslF345X03/ownership.xml…